SCHEMBL22062300

SCHEMBL22062300

Cc1cc2c3c(ccc2[nH]1)N(C(=O)c1cc2c4c(ccc2[nH]1)NCC4)CC3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK4 O00444 1/20 0.38
DAPK3 O43293 1/20 0.38
DYRK3 O43781 1/20 0.38
JAK2 O60674 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
PIM1 P11309 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CDK2 P24941 1/20 0.38
MAPK1 P28482 1/20 0.38
KDR P35968 1/20 0.38
MAPK8 P45983 1/20 0.38
CLK2 P49760 1/20 0.38
GSK3B P49841 1/20 0.38
CDK5 Q00535 1/20 0.38
DYRK1A Q13627 1/20 0.38
PIM3 Q86V86 1/20 0.38
MINK1 Q8N4C8 1/20 0.38
AURKB Q96GD4 1/20 0.38
PBK Q96KB5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22048825 0.91 RAB9A (0.38) PLK4DAPK3DYRK3JAK2PRKD3
SCHEMBL5384431 0.89 NPC1 (0.38) PLK4DAPK3DYRK3JAK2PRKD3
SCHEMBL532721 0.89 NPC1 (0.38) PLK4DAPK3DYRK3JAK2PRKD3
SCHEMBL5388939 0.88 RAB9A (0.41) PLK4DAPK3DYRK3JAK2PRKD3
SCHEMBL22871731 0.87 PLK4 (0.38) PLK4DAPK3DYRK3JAK2PRKD3
SCHEMBL29462567 0.87 NPC1 (0.36) PLK4DAPK3DYRK3JAK2PRKD3
SCHEMBL20764391 0.86 NPC1 (0.35) PLK4DAPK3DYRK3JAK2PRKD3
SCHEMBL7594289 0.83 HRH4 (0.34) PLK4DAPK3DYRK3JAK2PRKD3
SCHEMBL20195671 0.82 NPC1 (0.39) PLK4DAPK3DYRK3JAK2PRKD3
SCHEMBL13497870 0.78 ALDH1A1 (0.48) PLK4DAPK3DYRK3JAK2PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10677728-B2 Duplex stabilizing fluorescence quenchers for nucleic acid probes ELITECHGROUP B.V. (NL) 2020-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10677728-B2 Duplex stabilizing fluorescence quenchers for nucleic acid probes DDB1, DUT, DCLRE1B PLK4 4124/4885DAPK3 2700/4885DYRK3 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.